Detalles de la búsqueda
1.
Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.
J Geriatr Psychiatry Neurol
; 28(1): 67-79, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25009161
2.
A short-term, multicenter, placebo-controlled, randomized withdrawal study of a metabotropic glutamate 2/3 receptor agonist using an electronic patient-reported outcome device in patients with schizophrenia.
J Clin Psychopharmacol
; 34(5): 552-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25006819
3.
A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
Alcohol Clin Exp Res
; 38(2): 511-20, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24010675
4.
A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophrenia.
BMC Psychiatry
; 14: 351, 2014 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25539791
5.
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
BMC Psychiatry
; 13: 143, 2013 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23694720
6.
The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial.
BMC Psychiatry
; 13: 320, 2013 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24283222
7.
Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP).
J Psychopharmacol
; 37(11): 1051-1057, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37522187
8.
Adverse events in healthy subjects exposed to single and multiple doses of LY2140023 monohydrate: pooled results from 10 phase 1 studies.
J Clin Psychopharmacol
; 32(3): 408-11, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22544017
9.
Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial.
BMC Med Res Methodol
; 12: 142, 2012 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22974273
10.
Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.
BMC Psychiatry
; 12: 222, 2012 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23216976
11.
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension.
Schizophr Res
; 248: 271-278, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115192
12.
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.
J Psychopharmacol
; 36(4): 498-506, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35212240
13.
Clinical correlates of early onset antipsychotic treatment resistance.
J Psychopharmacol
; 36(11): 1226-1233, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36268751
14.
A predictor model of treatment resistance in schizophrenia using data from electronic health records.
PLoS One
; 17(9): e0274864, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121864
15.
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia.
J Clin Psychopharmacol
; 31(3): 349-55, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21508856
16.
Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuation.
Psychiatry Res
; 189(3): 463-8, 2011 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21684017
17.
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.
Psychiatry Res
; 187(1-2): 42-8, 2011 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21168920
18.
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.
BMC Psychiatry
; 11: 23, 2011 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21306626
19.
The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial.
BMC Psychiatry
; 11: 203, 2011 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22204569
20.
Early onset of antipsychotic action in schizophrenia: evaluating the possibility of shorter acute efficacy trials.
J Clin Psychopharmacol
; 30(3): 286-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20473064